INTRODUCTION HYPOTHESIS
The recent controversy surrounding the putative link between fertility medications and ovarian epithelial cancer (1-3) has brought attention to the reproductive factors influencing the development of this malignancy but has, as yet, failed to provide an adequate explanation of how these factors may interact to promote a malignant transformation of the ovarian epithelium. The concept of "incessant ovulation" (4) has been proposed as an explanation for the protective effects of oral contraceptives and parity upon the incidence of ovarian epithelial carcinoma. However, this explanation seems inadequate, as the magnitude of the protection afforded by a single pregnancy is disproportionally greater than that which would be expected from the number of ovulations which are avoided during gestation. Even with subsequent lactation amenorrhea, the number of ovulations avoided by one pregnancy progressing to term is no more than 12 to 15, which is less than 5% of the ovulations experienced by a normally ovulatory woman during a reproductive lifetime, yet the protective effect of a single gestation is approximately 40% (1) . The use of oral contraceptives also confers protection against ovarian epithelial cancer, which may reach 70% in women using these medications for more than 6 years (l). However, less than 20% of lifetime ovulations are prevented during 6 years of anovulation induced by oral contraceptives. Furthermore, the age at neither menopause nor men-A decreased risk of ovarian epithelial carcinoma in women who undergo tubal ligation or hysterectomy (without concomitant oophorectomy) has recently been confirmed by the Nurses' Health study cohort (5) . No clear explanation for this beneficial effect exists. One possible mechanism may be that interruption (or removal) of the oviducts provides a block to the peritoneal transport of perineal talc (5, 6) . The alternative hypothesis which I propose here is that the occlusion of the oviducts prevents ovarian epithelial cancer by preventing retrograde menstruation, the resulting activation of peritoneal macrophages, and the associated development of endometriosis.
Endometriosis is a well-described, relatively common condition, which affects women during the reproductive years (7) . Endometriosis is primarily thought to be due to retrograde menstruation, with subsequent implantation of the endometrial cells upon .the peritoneal lining. It is associated with an increased volume of peritoneal fluid, which contains inflammatory cells, notably macrophages, and a variety of somatic symptoms. Endometriosis, like ovarian cancer, is associated with infertility (8) . It is suppressed and may be prevented by early pregnancy and the use of oral contraceptives. Its incidence is diminished by the interruption of the oviduct.
It is unlikely that an implant of endometriosis on the peritoneal surface at a location distant from the ovary could directly induce malignant transformation in the ovarian epithelium. However, the inflammatory peritoneal exudate associated with endometriosis is in direct contact with the ovarian epithelium, regardless of where the actual implants may be located. It is known that endometriosis may lead to the formation of adhesions which may be vascular, thus confirming the presence of angiogenic and other growth factors in the peritoneal fluid. These factors may then act by paracrine stimulation upon the ovarian epithelium to stimulate growth and/or repair and thus increase the likelihood of malignant transformation.
The precise reason for the association between increased numbers of macrophages in the peritoneal cavity and endometriosis is not clear and a causeand-effect relationship has not been established (9,10). Thus, endometriosis may act to promote the development of ovarian epithelial cancer if endometriotic implants cause irritation and the consequent inflammatory reaction. Alternately, if the inflammatory reaction is due to retrograde menstruation and not due to endometriosis per se, then endometriosis may merely be a marker of the inciting cause.
The endometriosis hypothesis provides an explanation for the association between ovarian cancer and infertility, and accounts for the observation that pregnancy and oral contraceptives exert a disproportionately high protective effect upon the incidence of ovarian cancer. Additionally, it suggests a mechanism for the protective effects of tubal ligation and simple hysterectomy. If the association between perineal talc and ovarian epithelial cancer is due'to a foreign-body reaction and activation of peritoneal macrophages as occurs in endometriosis, this effect could also be explained.
A link between endometriosis and ovarian epithelial cancer has recently been made (1 I). However, this report focused on the malignant transformation of ovarian endometriotic lesions and the association with endometriosis involved primarily endometrioid and clear-cell histologic types. The Rossing et al. study (2) was the only report to list histologic type, and only 1 of 11 tumors was of the endometrioid designation. However, the endometriosis hypothesis is not limited to a particular cell type of malignancy, as the postulated effect is that of direct paracrine stimulation of the epithelium, which would be expected to lead to any of the various cell types of ovarian epithelial malignancies.
The weakness of the endometriosis hypothesis lies in the unpredictability of endometriosis. Not all women with retrograde menstruation develop endometriosis, and conversely, the amount of peritoneal exudate, adhesion formation, and neovascularization among women with endometriosis is variable. Nevertheless, epidemiologic studies should be able to discern some degree of correlation.
RAMIFICATIONS
If this paradigm is correct, then other conditions which are associated with or are protective of endometriosis should be related in an analogous manner to ovarian epithelial carcinoma. In particular, amenorrhea should be protective and hypermenorrhea should be a risk factor for ovarian epithelial cancer. Long-term follow-up of patients with endometriosis should reveal an increase in the incidence of ovarian epithelial cancer, especially if adhesions are present. The use of fertility drugs may be a marker of endometriosis-associated infertility, particularly infertility which resists treatment and may thus lead to long-term use of these medications (2) . Therefore, it is the thesis of this communication that epidemiologic studies investigating the association between fertility drugs and ovarian epithelial carcinoma are investigating a confounder rather than a cause.
INTRODUCTION
Hyperreactio luteinalis (HL) is the second most common ovarian disorder of pregnancy after luteoma of pregnancy and is characterized by bilateral cystic enlargement of ovaries (1) . The ovaries may be moderately to massively enlarged by multiple luteinized follicle cysts, secondary to stimulation with hCG and gonadotropins (2) . HL is most often associated with gestational trophoblastic disease, fetal hydrops, and multiple gestations, but this benign condition is occasionally observed during normal pregnancy with normal hCG levels. An iatrogenic form occurs in a variable proportion of women undergoing ovulation induction. HL is managed conservatively with preservation of the affected ovaries. Surgical intervention is usually performed only to remove infarcted tissue, control hemorrhage, or reduce ovarian size in patients with associated virilization. In rare cases, the cysts persist and are subsequently biopsied (3) .
This report describes an unusual case of bilateral serous cystadenofibromas clinically mimicking bilateral persistent bilateral hyperactive luteinalis during a normal singleton pregnancy achieved by controlled ovarian hyperstimulation and in vitro fertilization. These ovarian cysts developed during the pregnancy and partially regressed postpartum. Persistent enlargement at 2-year follow-up prompted surgical intervention.
CASE REPORT
A 3 l-year-old nulligravida female presented with a complaint of 2.5 years of infertility. Her initial infertility evaluation included a normal transvaginal ultrasound, laparoscopy, and hysteroscopy. The semen analysis was also normal and she was found to have idiopathic infertility.
The patient elected to undergo ovulation induction and in vitro fertilization (IVF) without any prior cycles of COH. Following her third cycle of IVF, she became pregnant. Transvaginal ultrasound done 26 days posttransfer documented a singleton intrauterine pregnancy with fetal cardiac activity. No abnormal adnexal masses or free fluid was noted.
A follow-up transvaginal ultrasound scan by her obstetrician at 5 weeks posttransfer revealed hyperstimulated ovaries measuring approximately 7 cm. During the pregnancy, larger cystic ovaries developed, from 14.4 x 12.5 and 11.1 × 8.6 cm at 17 weeks to 22.8 X 16.2 and 14.4 X 11.7 cm at 22 weeks, respectively.
The patient had a normal spontaneous vaginal delivery of a 3595-g female infant at 39 weeks' gestation. No maternal or fetal virilization was noted at birth.
Her enlarged cystic ovaries persisted and were noted at her 1-tnonth postpartum follow-up exam. Ultrasound results revealed the right ovary to be 19.2 x 17.9 X 13.3 cm and the left ovary to be 12.4 X 11.9 x 8.6 cm. She was followed with four ultrasound exams during her 10-month follow-up, while her condition was noted to improve. Her I 0-month postpartum scan revealed a fight ovary measuring 7.0 x 3.4 x 5.3 cm containing a thin-walled sonolucent structure measuring 4.3 × 4.5 X 4.9 cm with low-level echoes. The left ovary measured 7.0 × 3.3 × 5.1 cm and also contained a thin-walled sonolucent structure measuring 4.6 x 2.6 X 3.3 cm with clear fluid. The patient
